Drug Profile
Research programme: HIV therapeutics - HIV Cure Center
Latest Information Update: 28 Mar 2022
Price :
$50
*
At a glance
- Originator HIV Cure Center
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Mar 2022 No recent reports of development identified for research development in HIV-infections in USA
- 10 Mar 2020 Early reaserch development is still ongoing for HIV infections in USA
- 10 Mar 2020 ViiV Healthcare and University of North Carolina renews research partnership for additional five years